Status:
RECRUITING
Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma
Lead Sponsor:
National Cancer Center, Korea
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Biliary Tract Carcinoma
Radiotherapy
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
\[Study objectives\] To evaluate the efficacy and safety of the combined treatment of radiotherapy and endoscopic intraductal radiofrequency ablation in patients with locoregional extrahepatic cholang...
Detailed Description
○ Study flow The clinical study will be conducted in the following order. Of patients with extrahepatic cholangiocarcinoma requiring biliary drainage, those who meet the inclusion criteria and consent...
Eligibility Criteria
Inclusion
- Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
- Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Exclusion
- Patients who refuse to sign the informed consent
- Patients with metastatic cancer (stage IV) or malignant ascites
- Patients with intrahepatic cholangiocarcinoma
- Patients who are unable to undergo endoscopic procedures as determined by the investigator.
- Patients with a life expectancy of 3 months or less
- Patients with ID-RFA contraindications: pacemaker, pregnancy, uncorrected bleeding tendency (PT INR \> 1.5, platelets \< 50,000/mm3)
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2030
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT06168292
Start Date
April 1 2024
End Date
June 30 2030
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center, Korea
Goyang-si, Other, South Korea, 10408